Amber Pharmacy and ALR Technologies Team Up to Provide ALR Technologies' Constant Health Companion to Organ Transplant Patients

Amber Pharmacy Provides Specialized Care and Personal Solutions to Transplant Patients Nationwide

Richmond, Virginia, UNITED STATES

WINSTON-SALEM, NC -- (MARKET WIRE) -- December 12, 2006 -- ALR Technologies, Inc. (OTCBB: ALRT) announces they have reached agreement with Amber Pharmacy, based in Omaha, NE, for Amber Pharmacy to provide the Constant Health Companion™ patient compliance system to organ transplant patients across the nation. Amber Pharmacy provides specialized care and personal solutions to thousands of transplant patients in the U.S. They have offices in Omaha, Philadelphia, Dallas and Chicago.

According to Tim Kaplan, COO of Amber Pharmacy, transplant coordinators are continuously asking about ways to improve their patients' compliance. "As incredible as it may sound, many organ transplant recipients do not adhere to their medication regimen and we are always talking to transplant coordinators about ways to improve the patient's adherence. We're excited about the potential for the Constant Health Companion to bring this much-needed service to the thousands of patients who receive the life-sustaining organs. The ability to monitor the patient's compliance is likewise essential because if a person is not being compliant we will know about it much earlier than previously."

"Our plans are to begin offering the Constant Health Companion in February of 2007 and in the meantime we'll be putting together a program for use with our current patients and with our transplant program coordinators. There are more than 30,000 new recipients of organs each year and the availability of the Constant Health Companion can help change their lives."

The Constant Health Companion is a compliance reminder and monitoring system that alerts the patient when it's time to take a medication or treatment; displays the exact actions to take on a screen and the patients' compliance can be remotely monitored by a health care provider. The Constant Health Companion has been in use, with positive results, in pilots with transplant patients since February 2006. Missed medications and treatments or even lateness of administration can result in adverse affects and complications. Losing a transplanted organ has the obvious health effects with the patient as well as hundreds of thousands of dollars in additional costs to health insurance providers.

Noncompliance is widespread in recipients of life-sustaining organs and the necessity for the patient to adhere to the medications and treatments is so important due to the life-saving nature of the procedure. Patients who are noncompliant with transplant medications have lower anti-rejection drug levels, more acute rejection, and more chronic graft loss and medication noncompliance is a leading cause of morbidity in pediatric transplant recipients.

About Amber Pharmacy.

Amber Pharmacy focuses on the special needs of transplant patients and those in other chronic disease states. Amber Pharmacy works with over 150 transplant centers throughout the country in providing specialized care and personal solutions to patients. By utilizing the services of Amber Pharmacy, patients achieve a much higher compliance rate thus improving outcomes and lowering their overall cost of healthcare. Amber Pharmacy has locations in Omaha, Dallas, Chicago and Philadelphia. More information about Amber can be found at their website, or they can be reached by email at

About ALR Technologies, Inc.

ALR Technologies, Inc. (ALRT) specializes in health and disease management products and services, and designs and manufactures health management compliance products and compliance monitoring and intervention systems to meet the needs for several targeted user groups. ALRT's system, branded Constant Health Companion™, fills a serious gap in standard disease management practices in the U.S. It provides for continued compliance oversight to help keep people healthy, whether they suffer from diabetes, heart disease, asthma, have had an organ transplant or other serious conditions. More information on ALR Technologies and its products can be found at More information about the Constant Health Companion can be found at:

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate," "expect," "anticipate," "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

Contact Information: Public and Investor Relations: Mercom Capital Group, llc tel: 1.512.828.6645 e-mail: Email Contact